• Join
  • Login
  • Contact

Search abstracts / presentations

Drug residues in the environment: levels and risks

  • In: G17 - Pharmaceuticals and the environment on Monday, 3 September 2007, 9:00-12:00
  • At: Beijing (China) (2007)
  • Type: Presentation
  • By: WENNMALM, Åke (Stockholm County Council, Stockholm, Sweden)
  • Abstract:

    Pharmaceutical products used by patients are excreted via their urine or faeces. The pharmaceutical residues may consist of intact active ingredient, or breakdown products (metabolites) with or without biological effect. In urban societies with developed sewage systems, such drug residues excreted from patients usually end up in the wastewater


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses